Repository logo
 
Publication

Internal ribosome entry site-mediated translation of UPF1 contributes to its oncogenic role in colorectal cancer

dc.contributor.authorLacerda, Rafaela
dc.contributor.authorMenezes, Juliane
dc.contributor.authorElias, Adriana
dc.contributor.authorRomão, Luísa
dc.date.accessioned2024-01-22T10:36:10Z
dc.date.embargo2028-12-31
dc.date.issued2023-01-26
dc.description.abstractColorectal cancer (CRC) is the third cause of death worldwide and projections point towards an increase for the next two decades. Many genes are misregulated in CRC, contributing to the development of the disease. Up-frameshift 1 (UPF1) is involved in many cellular mechanisms such as nonsense-mediated mRNA decay, cell cycle progression, or telomere maintenance and homeostasis. It also works as a tumour suppressor protein in most cancers but not in CRC, in which UPF1 plays an oncogenic role. We used the Xena platform to perform in silico analyses that revealed UPF1 is overexpressed in CRC contrary to several other analysed cancers. Besides, UPF1 expression levels are increased in CRC compared to the counterpart normal tissues. Experimentally, we confirmed these data and observed that endogenous UPF1 expression is maintained in different CRC cell lines under endoplasmic reticulum (ER) stress. To understand the mechanism underlying such maintenance, we used a bicistronic reporter construct to test whether UPF1 5’UTR can mediate alternative translation initiation and we concluded that such sequence contains an internal ribosome entry site (IRES) that maintains UPF1 expression in both normal and stress conditions in a 5’ cap-independent way. Deletional and mutational analysis of UPF1 5’UTR showed that nucleotides 1–100 (stem loop (SL) I) and 151–275 (SL III) — out of 275 nucleotides — are the minimal required sequences for the IRES to work properly. Using RNA antisense oligonucleotides (ASOs) targeting UPF1 IRES SL I and III, we observed a reduced UPF1 expression in HCT116 (CRC) cells. Altogether, these results suggest that UPF1 expression levels are maintained by the IRES-mediated translation mechanisms under conditions impairing canonical translation, such as those that mimic the tumour microenvironment. Thus, ASOs may be an upcoming therapy to target such alternative mechanism of translation initiation and prevent CRC development.pt_PT
dc.description.sponsorshipWork supported by INSA and UIDB/04046/2020 (DOI: 10.54499/UIDB/04046/2020 ) and UIDP/04046/2020 (DOI: 10.54499/UIDP/04046/2020) Centre grants from FCT, Portugal (to BioISI).pt_PT
dc.description.versionN/Apt_PT
dc.identifier.urihttp://hdl.handle.net/10400.18/8932
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.relationBiosystems and Integrative Sciences Institute
dc.relationBiosystems and Integrative Sciences Institute
dc.subjectColorectal Cancerpt_PT
dc.subjectUp-frameshift 1 (UPF1)pt_PT
dc.subjectGenómica Funcionalpt_PT
dc.subjectExpressão Génicapt_PT
dc.subjectGenómica Funcional e Estruturalpt_PT
dc.titleInternal ribosome entry site-mediated translation of UPF1 contributes to its oncogenic role in colorectal cancerpt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.awardTitleBiosystems and Integrative Sciences Institute
oaire.awardTitleBiosystems and Integrative Sciences Institute
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04046%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04046%2F2020/PT
oaire.citation.conferencePlaceLisboa, Portugalpt_PT
oaire.citation.titleRNA in Disease - IX ptRNA meeting, 26-27 January 2023pt_PT
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsembargoedAccesspt_PT
rcaap.typeconferenceObjectpt_PT
relation.isProjectOfPublicationdc433369-36fd-4935-bd52-c56aa49c72e1
relation.isProjectOfPublicatione8390b4d-1833-4925-a0ab-5fff0527efaa
relation.isProjectOfPublication.latestForDiscoverydc433369-36fd-4935-bd52-c56aa49c72e1

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
poster_ptRNA.pt.pdf
Size:
770.05 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: